Published mark
UNITED THERAPEUTICS Corp
NASDAQ: UTHR. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:2be3e567-1127-420a-bbd3-bb8779437f4f
- SEC CIK
- 0001082554
- Record version
- vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
- Newest evidence
- Feb 25, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Martine RothblattSince Feb 25, 2026
- Chair
- Not published
- Independent
- 11 / 1212 directors published
- Published claims
- 403 distinct sources
- Evidence records
- 90 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
CFO CHANGED
James C. Edgemond executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
EffectiveEffective Feb 25, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Financial Officer and Treasurer | James C. Edgemond | Feb 2026 | current | Source reportedE3 |
| Chairperson and Chief Executive Officer | Martine Rothblatt | Feb 2026 | current | Source reportedE4 |
| Chairperson and Chief Executive Officer | Martine Rothblatt, Ph.D., J.D., M.B.A. | Feb 2026 | current | Source reportedE5 |
| President and Chief Operating Officer | Michael Benkowitz | Feb 2026 | current | Source reportedE6 |
| Executive Vice President, General Counsel, and Corporate Secretary | Paul A. Mahon | Feb 2026 | current | Source reportedE7 |
| Executive Vice President, General Counsel, and Corporate Secretary | Paul A. Mahon, J.D. | Feb 2026 | current | Source reportedE8 |
Board of directors
Evidence12 directors published. 11 of 12 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Christopher Causey | Independent | 2003 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| Christopher Patusky | Independent | 2002 | Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Jan Malcolm | Independent | 2024 | None published | Source reportedE2 |
| Judy Olian | Independent | 2015 | Audit | Source reportedE2 |
| Linda Maxwell | Independent | 2020 | Audit | Source reportedE2 |
| Louis Sullivan | Independent | 2002 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Martine Rothblatt | Not independent | 1996 | None published | Source reportedE2 |
| Nilda Mesa | Independent | 2018 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Ray Kurzweil | Independent | 2002 | None published | Source reportedE2 |
| Raymond Dwek | Independent | 2002 | Compensation | Source reportedE2 |
| Richard Giltner | Independent | 2009 | Audit, chairAudit · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Travis Thompson | Independent | 2010 | Audit | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Richard Giltner | Richard Giltner, Christopher Causey, Judy Olian, Linda Maxwell, Travis Thompson | Not described in the published record |
| Audit · Chair; Nominating and Governance | Not published | Richard Giltner | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Christopher Causey | Not described in the published record |
| Compensation | Christopher Patusky | Christopher Patusky, Louis Sullivan, Nilda Mesa, Raymond Dwek | Not described in the published record |
| Compensation · Chair; Nominating and Governance | Not published | Christopher Patusky | Not described in the published record |
| Compensation; Nominating and Governance | Not published | Louis Sullivan, Nilda Mesa | Not described in the published record |
| Nominating and Governance | Christopher Causey | Christopher Causey, Christopher Patusky, Louis Sullivan, Nilda Mesa, Richard Giltner | Not described in the published record |
Committee RecordAudit: Chair Richard Giltner; Members Richard Giltner (Chair); Christopher Causey; Judy Olian; Linda Maxwell; Travis Thompson
Committee AppointmentRichard Giltner: chair, Audit
Committee AppointmentChristopher Causey: member, Audit
Committee AppointmentJudy Olian: member, Audit
Committee AppointmentLinda Maxwell: member, Audit
Committee AppointmentTravis Thompson: member, Audit
Committee RecordCompensation: Chair Christopher Patusky; Members Christopher Patusky (Chair); Louis Sullivan; Nilda Mesa; Raymond Dwek
Committee AppointmentChristopher Patusky: chair, Compensation
Committee AppointmentLouis Sullivan: member, Compensation
Committee AppointmentNilda Mesa: member, Compensation
Committee AppointmentRaymond Dwek: member, Compensation
Committee RecordNominating and Governance: Chair Christopher Causey; Members Christopher Causey (Chair); Christopher Patusky; Louis Sullivan; Nilda Mesa; Richard Giltner
Committee AppointmentChristopher Causey: chair, Nominating and Governance
Committee AppointmentChristopher Patusky: member, Nominating and Governance
Committee AppointmentLouis Sullivan: member, Nominating and Governance
Committee AppointmentNilda Mesa: member, Nominating and Governance
Committee AppointmentRichard Giltner: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerMartine Rothblatt, Chairperson and Chief Executive Officer, from Feb 25, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingUTHR (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 17, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameUNITED THERAPEUTICS Corp
Entity StatusPublic listing published
Published FactUS
Published FactHealthcare
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- James C. EdgemondChief Financial Officer and Treasurercompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:18
- Martine RothblattChairperson and Chief Executive Officer; Directorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:19, company:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:12
- Martine Rothblatt, Ph.D., J.D., M.B.A.Chairperson and Chief Executive Officercompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:20
- Michael BenkowitzPresident and Chief Operating Officercompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:21
- Paul A. MahonExecutive Vice President, General Counsel, and Corporate Secretarycompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:22
- Paul A. Mahon, J.D.Executive Vice President, General Counsel, and Corporate Secretarycompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:23
- Christopher CauseyDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:6
- Christopher PatuskyDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:7
- Jan MalcolmDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:8
- Judy OlianDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:9
- Linda MaxwellDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:10
- Louis SullivanDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:11
- Nilda MesaDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:13
- Ray KurzweilDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:14
- Raymond DwekDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:15
- Richard GiltnerDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:16
- Travis ThompsonDirectorcompany:2be3e567-1127-420a-bbd3-bb8779437f4f:leadership_role:17
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 9 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 5 Claims.
- E2sec proxy. Published Apr 29, 2025. Retrieved May 6, 2026. Cited by 12 Claims.
- E3sec filing. Published Feb 25, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E4sec filing. Published Feb 25, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E5sec filing. Published Feb 25, 2026. Retrieved May 6, 2026. Cited by 1 Claim.
- E6sec filing. Published Feb 25, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E7sec filing. Published Feb 25, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E8sec filing. Published Feb 25, 2026. Retrieved May 6, 2026. Cited by 1 Claim.
- E9board_seats. board seats. Cited by 17 Claims.
What changed in version public-1:ro-d751713988987e9331980363e24189ce
vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 17, 2026- James C. Edgemond executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Martine Rothblatt executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Martine Rothblatt, Ph.D., J.D., M.B.A. executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Michael Benkowitz executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Paul A. Mahon executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Paul A. Mahon, J.D. executive of UNITED THERAPEUTICS Corp, effective 2026-02-25.
- Jan Malcolm seat on UNITED THERAPEUTICS Corp, effective 2024-01-01.
- Linda Maxwell seat on UNITED THERAPEUTICS Corp, effective 2020-01-01.
- Nilda Mesa seat on UNITED THERAPEUTICS Corp, effective 2018-01-01.
- Nilda Mesa member of Compensation; Nominating and Governance, effective 2018-01-01.
- Judy Olian seat on UNITED THERAPEUTICS Corp, effective 2015-01-01.
- Travis Thompson seat on UNITED THERAPEUTICS Corp, effective 2010-01-01.
- Richard Giltner seat on UNITED THERAPEUTICS Corp, effective 2009-01-01.
- Audit · Chair; Nominating and Governance committee of UNITED THERAPEUTICS Corp, effective 2009-01-01.
- Richard Giltner member of Audit · Chair; Nominating and Governance, effective 2009-01-01.
- Christopher Causey seat on UNITED THERAPEUTICS Corp, effective 2003-01-01.
- Audit; Nominating and Governance · Chair committee of UNITED THERAPEUTICS Corp, effective 2003-01-01.
- Christopher Causey member of Audit; Nominating and Governance · Chair, effective 2003-01-01.
- Christopher Patusky seat on UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Louis Sullivan seat on UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Ray Kurzweil seat on UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Raymond Dwek seat on UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Compensation · Chair; Nominating and Governance committee of UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Christopher Patusky member of Compensation · Chair; Nominating and Governance, effective 2002-01-01.
- Compensation; Nominating and Governance committee of UNITED THERAPEUTICS Corp, effective 2002-01-01.
- Louis Sullivan member of Compensation; Nominating and Governance, effective 2002-01-01.
- Martine Rothblatt seat on UNITED THERAPEUTICS Corp, effective 1996-01-01.